INTERNATIONAL PATENT: INSTITUTO DE INVESTIGACION BIOMEDICA DE SALAMANCA DE LA FUNDACION INSTITUTO CIENCIAS DE LA SALUD DE CASTILLA Y LEON, UNIVERSIDAD DE SALAMANCA FILES APPLICATION FOR "TRIMETHOXYSTYRYL DERIVATIVES FOR USE IN THE TREATMENT OF PACLITAXEL-RESISTANT CANCER"

GENEVA, Sept. 29 -- INSTITUTO DE INVESTIGACION BIOMEDICA DE SALAMANCA DE LA FUNDACION INSTITUTO CIENCIAS DE LA SALUD DE CASTILLA Y LEON (Hospital Universitario de Salamanca,Edificio Virgen de la Vega, 10ª pl.,Paseo San Vicente 58-18237007 Salamanca), UNIVERSIDAD DE SALAMANCA (Patio de Escuelas, 137008 Salamanca) filed a patent application (PCT/EP2025/057648) for "TRIMETHOXYSTYRYL DERIVATIVES FOR USE IN THE TREATMENT OF PACLITAXEL-RESISTANT CANCER" on Mar 20, 2025. With publication no. WO/2025/196192, the details related to the patent application was published on Sep 25, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Org...